| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.334 | 12.845 | 11.488 | 14.851 | 16.117 | 12.864 | 13.960 | 28.985 | 43.719 | 49.806 |
| Total Income - EUR | 3.334 | 12.845 | 11.488 | 14.851 | 16.117 | 12.864 | 13.960 | 28.985 | 43.719 | 49.806 |
| Total Expenses - EUR | 1.320 | 3.414 | 3.855 | 4.662 | 5.783 | 7.930 | 11.496 | 12.692 | 20.628 | 27.436 |
| Gross Profit/Loss - EUR | 2.014 | 9.431 | 7.634 | 10.190 | 10.334 | 4.934 | 2.464 | 16.293 | 23.091 | 22.370 |
| Net Profit/Loss - EUR | 1.914 | 9.046 | 7.289 | 9.744 | 9.850 | 4.548 | 2.146 | 15.780 | 22.749 | 20.999 |
| Employees | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Paula Neuromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 678 | 28.782 | 25.151 | 21.063 |
| Current Assets | 2.037 | 9.205 | 10.560 | 18.865 | 22.306 | 21.955 | 18.283 | 12.927 | 21.911 | 45.511 |
| Inventories | 0 | 0 | 0 | 0 | 492 | 0 | 0 | 456 | 455 | 2.502 |
| Receivables | 0 | 0 | 0 | 0 | 683 | 0 | 880 | 10.017 | 10.555 | 10.928 |
| Cash | 2.037 | 9.205 | 10.560 | 18.865 | 21.131 | 21.955 | 17.403 | 2.453 | 10.902 | 32.081 |
| Shareholders Funds | 1.959 | 9.099 | 8.643 | 16.938 | 21.824 | 15.828 | 12.165 | 24.941 | 45.593 | 58.296 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 79 | 106 | 1.917 | 1.927 | 482 | 6.126 | 6.796 | 17.756 | 2.456 | 9.259 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Paula Neuromed Srl